Cardiovascular hemodynamics and umbilical artery N-terminal peptide of proB-type natriuretic peptide in human fetuses with growth restriction

Ultrasound in Obstetrics and Gynecology

Volumn 29, Issue 3, 2007, Pages 296-303

  Girsen, A ^a   Ala Kopsala, M ^a   Makikallio K ^a   Vuolteenaho, O ^a   Rasanen J ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Fetal echocardiography; Heart failure; Natriuretic peptides; Physiology

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOPPLER FLOWMETRY; DUCTUS VENOSUS; FETUS; HEMODYNAMICS; HEPATIC VEIN; HUMAN; INTRAUTERINE GROWTH RETARDATION; PRIORITY JOURNAL; UMBILICAL ARTERY;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DATA INTERPRETATION, STATISTICAL; ECHOCARDIOGRAPHY, DOPPLER; EPIDEMIOLOGIC STUDIES; FEMALE; FETAL DISEASES; FETAL GROWTH RETARDATION; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PLACENTAL CIRCULATION; PLACENTAL INSUFFICIENCY; PREGNANCY; UMBILICAL ARTERIES;

EID: 33947376434     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.3934     Document Type: Article

References (32)

1. Rasanen J, Debbs RH, Huhta JC. Echocardiography in intrauterine growth restriction. Clin Obstet Gynecol 1997; 40: 796-803.
2. Hecher K, Bilardo CM, Stigter RH, Ville Y, Hackeloer BJ, Kok HJ, Senat MV, Visser GH. Monitoring fetuses with intrauterine growth restriction: a longitudinal study. Ultrasound Obstet Gynecol 2001; 18: 564-570.
3. Bilardo CM, Wolf H, Stigter RH, Ville Y, Baez E, Visser GH, Hecher K. Relationship between monitoring parameters and perinatal outcome in severe, early intrauterine growth restriction. Ultrasound Obstet Gynecol 2004; 23: 119-125.
4. Rasanen J, Wood DC, Weiner S, Ludomirski A, Huhta JC. Role of the pulmonary circulation in the distribution of human fetal cardiac output during the second half of pregnancy. Circulation 1996; 94: 1068-1073.
5. Rizzo G, Capponi A, Rinaldo D, Arduini D, Romanini C. Ventricular ejection force in growth-retarded foetuses. Ultrasound Obstet Gynecol 1995; 5: 247-255.
6. Walther T, Stepan H, Faber R. Dual natriuretic peptide response to volume load in the fetal circulation. Cardiovasc Res 2001; 49: 817-819.
7. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339: 321-328.
8. Hobbs FD, Davis RC, Roalfe AK, Hare R, Davies MK, Kenkre JE. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. Br Med J 2002; 324: 1498.
9. Nakamura T, Sakamoto K, Yamano T, Kikkawa M, Zen K, Hikosaka T, Kubota T, Azuma A, Nishimura T. Increased plasma brain natriuretic peptide level as a guide for silent myocardial ischemia in patients with non-obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2002; 39: 1657-1663.
10. de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, Hall C, Cannon CP, Braunwald E. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014-1021.
11. Acharya G, Wilsgaard T, Berntsen GK, Maltau JM, Kiserud T. Reference ranges for serial measurements of blood velocity and pulsatility index at the intra-abdominal portion, and fetal and placental ends of the umbilical artery. Ultrasound Obstet Gynecol 2005; 26: 162-169.
12. Hecher K, Campbell S, Snijders R, Nicolaides K. Reference ranges for fetal venous and atrioventricular blood flow parameters. Ultrasound Obstet Gynecol 1994; 4: 381-390.
13. Tulzer G, Khowsathit P, Gudmundsson S, Wood DC, Tian ZY, Schmitt K, Huhta JC. Diastolic function of the fetal heart during second and third trimester: a prospective longitudinal Doppler-echocardiographic study. Eur J Pediatr 1994; 153: 151-154.
14. Tsutsumi T, Ishii M, Eto G, Bailey KR, Oh JK, Rodeheffer RJ, Tajik AJ, Seward JB. Serial evaluation for myocardial performance in foetuses and neonates using a new Doppler index. Pediatr Int 1999; 41: 722-727.
15. DeVore GR, Siassi B, Piatt LD. Fetal echocardiography. IV. M-mode assessment of ventricular size and contractility during the second and third trimesters of pregnancy in the normal fetus. Am J Obstet Gynecol 1984; 150: 981-988.
16. Respondek ML, Kammermeier M, Ludomirsky A, Weil SR, Huhta JC. The prevalence and clinical significance of fetal tricuspid valve regurgitation with normal heart anatomy. Am J Obstet Gynecol 1994; 171: 1265-1270.
17. Fouron JC, Skoll A, Sonesson SE, Pfizenmaier M, Jaeggi E, Lessard M. Relationship between flow through the fetal aortic isthmus and cerebral oxygenation during acute placental circulatory insufficiency in ovine fetuses. Am J Obstet Gynecol 1999; 181: 1102-1107.
18. Baschat AA, Gembruch U, Reiss I, Gortner L, Diedrich K. Demonstration of fetal coronary blood flow by Doppler ultrasound in relation to arterial and venous flow velocity waveforms and perinatal outcome - the 'heart-sparing effect'. Ultrasound Obstet Gynecol 1997; 9: 162-172.
19. Ala-Kopsala M, Magga J, Peuhkurinen K, Leipala J, Ruskoaho H, Leppaluoto J, Vuolteenaho O. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides. Clin Chem 2004; 50: 1576-1588.
20. Tokola H, Hautala N, Marttila M, Magga J, Pikkarainen S, Kerkela R, Vuolteenaho O, Ruskoaho H. Mechanical load-induced alterations in B-type natriuretic peptide gene expression. Can J Physiol Pharmacol 2001; 79: 646-653.
21. Takahashi T, Allen PD, Izumo S. Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles. Correlation with expression of the Ca(2+)-ATPase gene. Circ Res 1992; 71: 9-17.
22. al-Ghazali W, Chita SK, Chapman MG, Allan LD. Evidence of redistribution of cardiac output in asymmetrical growth retardation. Br J Obstet Gynaecol 1989; 96: 697-704.
23. Makikallio K, Vuolteenaho O, Jouppila P, Rasanen J. Ultrasonographic and biochemical markers of human fetal cardiac dysfunction in placental insufficiency. Circulation 2002; 105: 2058-2063.
24. Rasanen J, Debbs RH, Wood DC, Weiner S, Weil SR, Huhta JC. Human fetal right ventricular ejection force under abnormal loading conditions during the second half of pregnancy. Ultrasound Obstet Gynecol 1997; 10: 325-332.
25. Groenning BA, Nilsson JC, Sondergaard L, Pedersen F, Trawinski J, Baumann M, Larsson HB, Hildebrandt PR. Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations. Am Heart J 2002; 143: 923-929.
26. Capponi A, Rizzo G, De Angelis C, Arduini D, Romanini C. Atrial natriuretic peptide levels in fetal blood in relation to inferior vena cava velocity waveforms. Obstet Gynecol 1997; 89: 242-247.
27. Harrington K, Thompson MO, Carpenter RG, Nguyen M, Campbell S. Doppler fetal circulation in pregnancies complicated by pre-eclampsia or delivery of a small for gestational age baby: 2. Longitudinal analysis. Br J Obstet Gynaecol 1999; 106: 453-466.
28. Magga J, Vuolteenaho O, Tokola H, Marttila M, Ruskoaho H. Involvement of transcriptional and posttranscriptional mechanisms in cardiac overload-induced increase of B-type natriuretic peptide gene expression. Circ Res 1997; 81: 694-702.
29. de Bold AJ, Bruneau BG, Kuroski de Bold ML. Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovasc Res 1996; 31: 7-18.
30. Sagnella GA. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci 1998; 95: 519-529.
31. Bakker J, Gies I, Slavenburg B, Bekers O, Delhaas T, van Dieijen-Visser M. Reference values for N-terminal pro-B-type natriuretic peptide in umbilical cord blood. Clin Chem 2004; 50: 2465.
32. Bar-Oz B, Lev-Sagie A, Arad I, Salpeter L, Nir A. N-terminal pro-B-type natriuretic peptide concentrations in mothers just before delivery, in cord blood, and in newborns. Clin Chem 2005; 51: 926-927.